Compile Data Set for Download or QSAR
Report error Found 49 Enz. Inhib. hit(s) with all data for entry = 2527
TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370104BDBM370104(US10233187, Example 42)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370103BDBM370103(US10233187, Example 41)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370102BDBM370102(US10233187, Example 40)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370101BDBM370101(US10233187, Example 39)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370105BDBM370105(US10233187, Example 43)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370095BDBM370095(US10233187, Example 33)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370093BDBM370093(US10233187, Example 31)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370100BDBM370100(US10233187, Example 38)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370099BDBM370099(US10233187, Example 37)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370097BDBM370097(US10233187, Example 35)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370072BDBM370072(US10233187, Example 10)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370071BDBM370071(US10233187, Example 9)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370070BDBM370070(US10233187, Example 8)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370076BDBM370076(US10233187, Example 14)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370075BDBM370075(US10233187, Example 13)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370074BDBM370074(US10233187, Example 12)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370073BDBM370073(US10233187, Example 11)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370064BDBM370064((E)-ethyl 6-(3,4-difluorobenzoyl)-3,4,4-trimethyl-...)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370063BDBM370063((E)-isopropyl 6-(3,4-difluorobenzoyl)-4,4-dimethyl...)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370067BDBM370067(US10233187, Example 5)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370065BDBM370065((E)-ethyl 6-(3,4-difluorobenzoyl)-3-(4-fluoropheny...)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370088BDBM370088(US10233187, Example 26)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370087BDBM370087(US10233187, Example 25)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370063BDBM370063((E)-isopropyl 6-(3,4-difluorobenzoyl)-4,4-dimethyl...)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370085BDBM370085(US10233187, Example 23)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370091BDBM370091(US10233187, Example 29)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370090BDBM370090(US10233187, Example 28)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370089BDBM370089(US10233187, Example 27)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370079BDBM370079(US10233187, Example 17)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370077BDBM370077(US10233187, Example 16 | US10233187, Example 15)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370077BDBM370077(US10233187, Example 16 | US10233187, Example 15)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370069BDBM370069(US10233187, Example 7)
Affinity DataEC50:  600nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370108BDBM370108(US10233187, Example 46)
Affinity DataEC50:  600nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370107BDBM370107(US10233187, Example 45)
Affinity DataEC50:  600nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370106BDBM370106(US10233187, Example 44)
Affinity DataEC50:  600nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370096BDBM370096(US10233187, Example 34)
Affinity DataEC50:  600nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370094BDBM370094(US10233187, Example 32)
Affinity DataEC50:  600nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370068BDBM370068(US10233187, Example 6)
Affinity DataEC50:  600nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370066BDBM370066((E)-ethyl 6-(3,4-difluorobenzoyl)-4,4-dimethyl-1,4...)
Affinity DataEC50:  600nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370098BDBM370098(US10233187, Example 36)
Affinity DataEC50:  600nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370092BDBM370092(US10233187, Example 30)
Affinity DataEC50:  600nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370080BDBM370080(US10233187, Example 18)
Affinity DataEC50:  600nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370111BDBM370111(US10233187, Example 49)
Affinity DataEC50:  600nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370084BDBM370084(US10233187, Example 22)
Affinity DataEC50:  600nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370083BDBM370083(US10233187, Example 21)
Affinity DataEC50:  600nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370082BDBM370082(US10233187, Example 20)
Affinity DataEC50:  600nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370110BDBM370110(US10233187, Example 48)
Affinity DataEC50:  5.50E+3nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370109BDBM370109(US10233187, Example 47)
Affinity DataEC50:  5.50E+3nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 370081BDBM370081(US10233187, Example 19)
Affinity DataEC50:  5.50E+3nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent